Please login to the form below

Not currently logged in

GE Healthcare re-launches online neurological campaign

MIND Online aims to improve understanding of conditions such as Alzheimer's disease

GE Healthcare MIND neurological campaignGE Healthcare has re-launched its MIND Online campaign, giving it a new website aimed at patients and carers affected by neurological disorders.

The website's resources are just one component of GE's global MIND - Making An Impact on Neurological Disorders - campaign, which seeks to identify gaps in current frameworks for the detection, diagnosis, and care of neurological disorders, and to propose viable solutions.

One issue that continues to be urgent has been the delay in diagnosis of a neurological disorder.

“Neurological disorders are progressive diseases. This means that with every passing day brain function is deteriorating. Earlier intervention may lead to a better outcome for those afflicted” said Dr Gabrielle Silver, head of neuroscience marketing at GE Healthcare. has been designed to provide a better understanding of disorders such as Alzheimer's, Parkinson's, MS, essential tremor and traumatic brain injury.

To help with early diagnosis, the website includes the 'Test your MIND' section, which contains a series of questions and tests to help those who suspect they - or a friend or relative - may be in the initial stages of a neurological disorder.

Its online resources include a 'MIND Stories' section in which patients, families and their caregivers can share stories and personal insights into how neurological disorders have affected them.

Also present is the 'MIND Facts' section, which focuses on the causes, symptoms, diagnosis and treatment of neurological disorders. In addition, the website will highlight current opinions of neurological disorders.

“We believe that patient awareness and diagnostic technology are two aspects that can be impactful,” said Dr Silver.

“Our investments in online resources like can help patients and their caregivers understand a lot more about these neurological conditions,” she added.

Article by
Tara Craig

3rd January 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...